Corvus Pharmaceuticals (CRVS) Capital Expenditures Growth (1y) (2016 - 2026)
Corvus Pharmaceuticals (CRVS) Capital Expenditures Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Corvus Pharmaceuticals |
1.00 Bn |
766.75 Mn |
- |
152.78% |
| Date | Value |
|---|
| Mar 31, 2026 |
152.78% |
| Dec 31, 2019 |
-93.59% |
| Sep 30, 2019 |
107.41% |
| Mar 31, 2019 |
166.67% |
| Dec 31, 2018 |
1,075.00% |
| Sep 30, 2018 |
-228.57% |
| Jun 30, 2018 |
-70.97% |
| Mar 31, 2018 |
-86.96% |
| Dec 31, 2017 |
78.95% |
| Sep 30, 2017 |
-62.16% |
| Jun 30, 2017 |
130.85% |
| Mar 31, 2017 |
-92.51% |
| Dec 31, 2016 |
-129.69% |
| Sep 30, 2016 |
115.44% |
| Jun 30, 2016 |
-173.81% |
| Mar 31, 2016 |
923.33% |
